Form 4: National Health Investors Director Robert T. Webb Reports Stock Option Grant and Beneficial Ownership
SEC Form 4
Director Robert T. Webb reports acquisition of stock options and updates to beneficial ownership of National Health Investors Inc. (NHI) common stock.
Summary
- Robert T. Webb, a director of National Health Investors Inc. (NHI), filed a Form 4 detailing changes in his beneficial ownership.
- The report indicates Webb acquired stock options to purchase 10,000 shares of common stock at an exercise price of $57.76 on February 23, 2024, exercisable immediately and expiring on February 23, 2029.
- Webb directly owns 63,339 shares of NHI common stock.
- Webb also has indirect ownership of 42,000 shares through the Nancy P. Webb Family Trust, where he serves as trustee.
- The report also lists existing stock options from previous years.
Sentiment
Score: 5
Explanation: This is a neutral disclosure of stock option grants and beneficial ownership, with no inherent positive or negative implications.
Industry Context
Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders. This allows investors to track the buying and selling activity of individuals with privileged information about the company's performance and prospects.
Stakeholder Impact
- Shareholders may be interested in tracking insider transactions as an indicator of management's confidence in the company.
Key Dates
| Date | Description |
|---|---|
| 02/21/2020 | Stock Options (Right to Buy) 2-21-2020 $90.79, Expiration Date 02/21/2025, Common Stock 25,000 |
| 02/25/2021 | Stock Options (Right to Buy) 2-25-2021 $69.2, Expiration Date 02/25/2026, Common Stock 25,000 |
| 02/25/2022 | Stock Option (Right to buy) 2022 $53.41, Expiration Date 02/25/2027, Common Stock 25,000 |
| 02/24/2023 | Stock Option (Right to Buy) 2023 $54.73, Expiration Date 02/24/2028, Common Stock 10,000 |
| 02/23/2024 | Date of Earliest Transaction |
| 02/23/2024 | Stock Option (Right to Buy) 2024 $57.76, Expiration Date 02/23/2029, Common Stock 10,000 |
| 02/27/2024 | Signature Date |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.